A novel nonsense variant in RHAG underlies a Nordic Rh null phenotype
Vox Sanguinis · 2023-08 · 118 (8) · 690-694
DOI: 10.1111/vox.13478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, online erschienen am 02.06.2023. Verfasst von Åsa Hellberg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Sweden. Hauptthemen laut MEDLINE: Rh-Hr Blood-Group System, Blood Group Antigens. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Avtal om Läkarutbildning och Forskning.
Abstract (Originalsprache)
Background and Objectives The extremely rare Rh null phenotype is characterized by the absence of all Rh antigens on erythrocytes. It is divided into the regulator and amorph types based on the underlying genetic background. The more common regulator type depends on critical variants silencing RHAG , which encodes RhAG glycoprotein, necessary for RhD/RhCE expression. Rh null cells have altered expression of glycophorin B and LW glycoprotein. Materials and Methods Four unrelated Rh null individuals were investigated. Serological testing was performed according to standard blood bank practice. RHD / RHCE and S/s allele‐specific Polymerase chain reaction (PCR) genotyping was done on genomic DNA using in‐house PCR assays. RHAG , and in some cases also RHD / RHCE , were sequenced. Initial s phenotyping results triggered additional serological investigation.
Results
Anti‐Rh29 was identified in all four individuals. Extended typing with anti‐S and anti‐s showed that the three samples predicted to type as s+ failed to react with 2 of 5 anti‐s. Sequence analysis of all 10 RHAG exons and the immediate intron/exon boundaries revealed a single nucleotide variant in the 3′‐end of intron 6, c.946 −2a>g in all samples. RHD / RHCE showed no alterations.
Conclusion
A novel Nordic Rh null allele was identified. In addition, it was shown that s+ Rh null red blood cells are not only U− but also have qualitative changes in their s antigen expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Sweden.
- Department of Laboratory Medicine, University Hospital of North Norway, Tromsø, Norway.
- Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, Uppsala, Sweden.
- Finnish Red Cross Blood Service, Helsinki, Finland.
- Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Region Västerbotten, Sweden.
- Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
ORCID-Profile: Martin L Olsson, Jill R Storry
Förderung
- Avtal om Läkarutbildning och Forskning
Zitieren
APA
Hellberg, Å., Arsenovic, M. G., Sørvoll, I. H., Lubenow, N., Sareneva, I., Haimila, K., Nordström, M., Olsson, M. L., & Storry, J. R. (2023). A novel nonsense variant in RHAG underlies a Nordic Rh null phenotype. Vox Sanguinis, 118(8), 690-694. https://doi.org/10.1111/vox.13478
Vancouver
Hellberg Å, Arsenovic MG, Sørvoll IH, Lubenow N, Sareneva I, Haimila K, et al. A novel nonsense variant in RHAG underlies a Nordic Rh null phenotype. Vox Sanguinis. 2023;118(8):690-694. doi:10.1111/vox.13478
BibTeX
@article{Hellberg2023,
author = {Hellberg, Åsa and Arsenovic, Mirjana Grujic and Sørvoll, Ingvild Hausberg and Lubenow, Norbert and Sareneva, Inna and Haimila, Katri and Nordström, Magnus and Olsson, Martin L and Storry, Jill R},
title = {A novel nonsense variant in RHAG underlies a Nordic Rh null phenotype},
journal = {Vox Sanguinis},
year = {2023},
volume = {118},
number = {8},
pages = {690--694},
doi = {10.1111/vox.13478}
}
EUVIMED